CONTINUEThis site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Find out more.
  1. Front Page
  2. News By Topic
  3. Brazil Reduces Duty On Specific Pharmaceuticals

Brazil Reduces Duty On Specific Pharmaceuticals

by Mike Godfrey, Tax-News.com, Washington

01 January 2016


Brazil has cut the import duty on three drugs that are used for kidney transplants and for treating lung and kidney cancer.

The reductions were made through CAMEX Resolution No. 120/2015, which was published in the Official Gazette on December 18, 2015.

Under the resolution, the import duty on basiliximab, a drug used in kidney transplants, was reduced from two percent to zero percent.

Meanwhile, the import duty on temsirolimus, a drug used to treat kidney cancer, was reduced from eight percent to zero percent.

Finally, the import duty on erlotinib hydrochloride, which is used in the treatment of lung cancer, pancreatic cancer, and several other types of cancer, was cut from eight percent to zero percent.

TAGS: tax | public health | private healthcare | tariffs | health care | tax rates | Brazil | tax breaks | import duty | trade

To see today's news, click here.

 















Tax-News Reviews

Cyprus Review

A review and forecast of Cyprus's international business, legal and investment climate.

Visit Cyprus Review »

Malta Review

A review and forecast of Malta's international business, legal and investment climate.

Visit Malta Review »

Jersey Review

A review and forecast of Jersey's international business, legal and investment climate.

Visit Jersey Review »

Budget Review

A review of the latest budget news and government financial statements from around the world.

Visit Budget Review »



Stay Updated

Please enter your email address to join the Tax-News.com mailing list. View previous newsletters.

By subscribing to our newsletter service, you agree to our Terms and Conditions and Privacy Policy.


To manage your mailing list preferences, please click here »